Jacob Gottlieb is the founder and head of Altium Capital. Gottlieb has made quite a name for himself in the investment world. His love of investing began in high school when he won a stock-picking contest. After high school he a B.A. (Magne Cum Laude) Economics from Brown University. With the intention of pursuing a medical career, he then earned an M.D. from NYU Medical School. However, after obtaining this degree he decided that a career in investing was the life for him. Therefore, in 2001 he worked for and obtained his Certified Financial Analyst designation.
While working toward this end, he was also employed by Sanford C. Bernstein & Co. as a buy-side analyst. After a few years, he became employed at Merlin Biomed Group and then Balyasny Asset Management. In 2005 Gottlieb partnered with several colleagues and family members to cofound Visium. For this venture, Gottlieb successfully raised over $300 million in investments. Over the next few years, it became extremely successful, growing to be an $8 billion dollar fund with a staff of 170 and offices in New York, London, and San Francisco.
Unfortunately, its huge success collapsed after three of its employees were charged and convicted of securities mismarking and insider trading. While the company might have continued, the damage to its reputation was irreparable. Because of this Gottlieb made the wise decision to shut down all of its operations. But this did not keep Gottlieb out of the financial game. He has since invested in both Oramed Pharmaceuticals Inc. and Sellas Life Sciences, both pharmaceutical companies. Experts also predict that both will be revolutionizing the medical world. They are especially excited about Oramed’s introduction of an oral insulin capsule which negates the need for the traditionally necessary insulin injection for patients that require them.
And as mentioned Gottlieb has also founded and leads Altium Capital, a hedge fund.
Find out more about Jacob Gottlieb: https://ideamensch.com/jacob-gottlieb/